Historical record - last NADAC publication: 7/5/2017
Product Information
BOTOX 100 UNITS VIAL is a brand product labeled by Allergan, Inc., priced at $597.5185 per EA under NDC 00023114501. Its NADAC has been published 234 times since Jan 22, 2014.
Strength
100 [USP'U]/1
Manufacturer
Allergan, Inc.NDC
00023114501
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRADERMAL; INTRAMUSCULAR
Last Updated
7/5/2017
Active Ingredients
BOTULINUM TOXIN TYPE AApproval Type
Biologic (BLA)
FDA Application
BLA103000On Market Since
12/15/1989
Pharmacological Classes
Price Statistics
The NADAC for BOTOX 100 UNITS VIAL has been published 234 times since Jan 22, 2014, and over the history we have for it it has risen 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $597.5185 per EA |
|---|---|
| All-time high | $597.5185 (Jul 11, 2018) |
| All-time low | $523.6875 (Jan 22, 2014) |
| Median price | $580.0884 |
| Average price | $569.2707 |
| Largest weekly change | +3.8% (Jan 13, 2016) |
| Weeks tracked | 234 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BOTOX 100 UNITS VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BOTOX 100 UNITS VIAL, manufactured by Allergan, Inc., is $597.5185 per EA (NDC 00023114501), effective Jul 11, 2018.
How has the price of BOTOX 100 UNITS VIAL changed over time?
Over the history we have for it, the NADAC for BOTOX 100 UNITS VIAL has risen 14.1%. It has been tracked across 234 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for BOTOX 100 UNITS VIAL?
Since Jan 22, 2014, the NADAC for BOTOX 100 UNITS VIAL has ranged from a low of $523.6875 (Jan 22, 2014) to a high of $597.5185 (Jul 11, 2018), with a median of $580.0884 per EA.
Are there cheaper alternatives to BOTOX 100 UNITS VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BOTOX 100 UNITS VIAL, but none are currently priced below it.
Who manufactures BOTOX 100 UNITS VIAL?
BOTOX 100 UNITS VIAL (NDC 00023114501) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification